Importance of baseline distribution of proteinuria in renal outcomes trials. Lessons from the Reduction of Endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study

Z. Zhang; S. Shahinfar; W.F. Keane; D. Ramjit; T.Z. Dickson; G.W. Gleim; Carl Erik Skibsted Mogensen; D. de Zeeuw; B.M. Brenner; S.M. Snapinn

Importance of baseline distribution of proteinuria in renal outcomes trials. Lessons from the Reduction of Endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study

Z. Zhang, S. Shahinfar, W.F. Keane, D. Ramjit, T.Z. Dickson, G.W. Gleim, Carl Erik Skibsted Mogensen, D. de Zeeuw, B.M. Brenner, S.M. Snapinn

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Review › Research

40 Citations (Scopus)

Original language	English
Journal	Journal of the American Society of Nephrology
Volume	16
Pages (from-to)	1775-1780
Number of pages	6
ISSN	1046-6673
Publication status	Published - 2005

Cite this

Zhang, Z., Shahinfar, S., Keane, W. F., Ramjit, D., Dickson, T. Z., Gleim, G. W., Mogensen, C. E. S., de Zeeuw, D., Brenner, B. M., & Snapinn, S. M. (2005). Importance of baseline distribution of proteinuria in renal outcomes trials. Lessons from the Reduction of Endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study. Journal of the American Society of Nephrology, 16, 1775-1780.

@article{41b33600aa8f11dabee902004c4f4f50,

title = "Importance of baseline distribution of proteinuria in renal outcomes trials. Lessons from the Reduction of Endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study",

author = "Z. Zhang and S. Shahinfar and W.F. Keane and D. Ramjit and T.Z. Dickson and G.W. Gleim and Mogensen, {Carl Erik Skibsted} and {de Zeeuw}, D. and B.M. Brenner and S.M. Snapinn",

year = "2005",

language = "English",

volume = "16",

pages = "1775--1780",

journal = "Journal of the American Society of Nephrology",

issn = "1046-6673",

publisher = "Wolters Kluwer Health",

}

Zhang, Z, Shahinfar, S, Keane, WF, Ramjit, D, Dickson, TZ, Gleim, GW, Mogensen, CES, de Zeeuw, D, Brenner, BM & Snapinn, SM 2005, 'Importance of baseline distribution of proteinuria in renal outcomes trials. Lessons from the Reduction of Endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study', Journal of the American Society of Nephrology, vol. 16, pp. 1775-1780.

Importance of baseline distribution of proteinuria in renal outcomes trials. Lessons from the Reduction of Endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study. / Zhang, Z.; Shahinfar, S.; Keane, W.F. et al.
In: Journal of the American Society of Nephrology, Vol. 16, 2005, p. 1775-1780.

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Review › Research

TY - JOUR

T1 - Importance of baseline distribution of proteinuria in renal outcomes trials. Lessons from the Reduction of Endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study

AU - Zhang, Z.

AU - Shahinfar, S.

AU - Keane, W.F.

AU - Ramjit, D.

AU - Dickson, T.Z.

AU - Gleim, G.W.

AU - Mogensen, Carl Erik Skibsted

AU - de Zeeuw, D.

AU - Brenner, B.M.

AU - Snapinn, S.M.

PY - 2005

Y1 - 2005

M3 - Review

SN - 1046-6673

VL - 16

SP - 1775

EP - 1780

JO - Journal of the American Society of Nephrology

JF - Journal of the American Society of Nephrology

ER -